NCCN Affirms Commitment to Cancer-Related Distress Resources Worldwide During Mental Health Awareness Month
The latest version of the National Comprehensive Cancer Network's Distress Thermometer and Problem List is available for free in more than 70 languages. PLYMOUTH MEETING, Pa., May 20, 2026 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—announces that the latest version of the NCCN Distress Thermometer and Problem List, a rapid validated screening tool (0-10...
Corti launches Symphony for Speech-to-Text
Clinical-grade speech models reduce word error rates by up to 93% versus generalist speech models and APIs, powering greater accuracy for the agentic era of healthcare. COPENHAGEN, Denmark, May 20, 2026 /PRNewswire/ -- Corti, the frontier lab for clinical-grade AI, today launched Symphony for Speech-to-Text: a new generation of clinical-grade speech-to-text...
Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
Study now open for enrollment at leading academic medical centers CARY, N.C. and BRADENTON, Fla., May 20, 2026 /PRNewswire/ -- Continuity Biosciences, LLC, a clinical-stage biotechnology company advancing precision drug delivery platforms, today announced the initiation of a Phase I, first-in-human clinical trial evaluating gemcitabine delivered via its iontophoretic oncology platform (IOP)...
Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
Study now open for enrollment at leading academic medical centers CARY, N.C. and BRADENTON, Fla., May 20, 2026 /PRNewswire/ -- Continuity Biosciences, LLC, a clinical-stage biotechnology company advancing precision drug delivery platforms, today announced the initiation of a Phase I, first-in-human clinical trial evaluating gemcitabine delivered via its iontophoretic oncology platform (IOP)...
METiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026
BEIJING, HANGZHOU, China and CAMBRIDGE, Mass., May 20, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a global leader in AI-powered drug delivery innovation, today announced that new preclinical data from its heart-targeted LNP program has been selected for a Late-Breaking oral presentation at the 2026 Controlled Release Society (CRS) Annual Meeting. Dr. Andong...
Malaysia Healthcare Travel Council (MHTC) Strengthens Regional Engagement and Malaysia Healthcare Brand Visibility Through Malaysia Fair Jakarta 2026
KUALA LUMPUR, Malaysia and JAKARTA, Indonesia, May 20, 2026 /PRNewswire/ -- As part of the Malaysia Year of Medical Tourism 2026 (MYMT 2026) initiative, Malaysia Healthcare continues to strengthen its strategic engagement within the Indonesian market through its participation at Malaysia Fair 2026, reinforcing Malaysia's position as a preferred healthcare destination among Indonesian healthcare travellers. Spearheaded by the Malaysia...
Celebrate National Physical Fitness & Sports Month: Breathe Better, Move Freely with Oxygen Support
NEW YORK, May 20, 2026 /PRNewswire/ -- May is National Physical Fitness & Sports Month, a time to celebrate staying active and prioritizing health at every stage of life. VARON, a leading provider of home oxygen concentrator and portable oxygen concentrator solutions, highlights how modern oxygen concentrator machine technology can support adults—from busy professionals to active seniors—in maintaining energy,...
Hyundai Bioscience: “Able to Supply Antiviral Drug in Event of Ebola or Hantavirus Spread”
SEOUL, South Korea, May 20, 2026 /PRNewswire/ -- Hyundai Bioscience announced on May 19th that it can supply clinical trial doses of its broad-spectrum antiviral drug XAFTY® in response to growing global concern over infectious disease outbreaks caused by Ebola and hantavirus. Hyundai Bioscience said that if the World Health Organization (WHO) or...
WuXi Biologics Hosts Third CRDMO Day in Japan, Accelerating Biopharma Innovation from IND to Commercialization
TOKYO, May 20, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), recently hosted its third CRDMO Day in Tokyo, bringing together senior leaders and experts from Japan's biopharmaceutical industry, exchanging the latest market insights and best practices in advancing biologics innovation from IND to commercialization. Leveraging its world-class quality systems, operational...
Haier Biomedical Publishes 2025 Sustainability Report: Committed to Building a Platform for Technology, Industry and Social Responsibility
QINGDAO, China, May 20, 2026 /PRNewswire/ -- Haier Biomedical (688139.SH), a global leader in life sciences and medical solutions, has released its 2025 Sustainability Report, providing a comprehensive overview of the company's measurable progress achieved in environmental, social, and governance with dedication to safer, greener, and more inclusive, accessible healthcare and life sciences worldwide. Within its LIFE sustainability framework...
